Engineered Transaminases for Lactam Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for synthesizing lactams, particularly substituted lactams, face challenges in efficiency, stereoselectivity, and mild reaction conditions, especially in producing specific stereoisomers.
Innovation Solution
Engineered transaminases based on the Arthrobacter sp. KNK168 enzyme with specific amino acid sequence modifications are used to convert dicarbonyl substrate compounds into lactams, allowing for direct formation of lactam products under mild conditions and enhanced stereoselectivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional methods (Beckman rearrangement, cyclization of amino acids) are used to synthesize lactams, then the synthesis can be performed with standard reagents and conditions, but the methods lack efficiency and stereoselectivity for producing specific stereoisomers
Solution Approach 1:
The patent changes the fundamental parameter of the reaction mechanism from chemical catalysis to enzymatic catalysis. By using transaminase enzymes, the reaction conditions are modified to occur under mild, aqueous conditions with high stereoselectivity, transforming the synthesis approach while maintaining ease of manufacture through simplified reaction protocols
Solution Approach 2:
The patent replaces conventional chemical mechanisms with biological catalysis. The transaminase enzyme system substitutes for traditional chemical reagents and conditions, providing a more efficient and stereoselective pathway for lactam synthesis while maintaining operational simplicity
2Productivity
If engineered transaminases are used to convert dicarbonyl substrates to lactams, then stereoselectivity and efficiency are improved, but the method requires specific enzyme modifications and substrate structures
Solution Approach 1:
The patent segments the enzyme engineering process into specific amino acid position modifications based on the Arthrobacter sp. KNK168 wild-type sequence. By identifying and modifying specific positions (such as positions 72, 80, 84, 103, 115, 117, 122, 124, 126, 128, 134, 136, 139, 140, 143, 150, 152, 155, 156, 159, 160, 165, 168, 176, 192, 196, 199, 208, 209, 215, 223, 227, 231, 266, 267, 269, 273, 282, 284, 295, 296, 300, 311, 312, 320, 324, 325, 327), the patent achieves improved productivity through systematic enzymatic modifications
Solution Approach 2:
The patent modifies enzymatic parameters by changing amino acid sequences at specific positions to optimize substrate binding, catalytic activity, and stereoselectivity. These parameter changes in the enzyme structure enable high conversion efficiency while maintaining manageable complexity through targeted modifications rather than complete redesign
3Manufacturing precision
If multiple steps involving Pd-mediated reduction are used to form stereoisomeric lactams, then specific stereoisomers can be produced, but the synthesis becomes complex and less efficient
Solution Approach 1:
The patent segments the multi-step synthesis into a single enzymatic transformation step. By using transaminase enzymes with specific substrate recognition, the process achieves stereoisomer specificity in one step rather than requiring multiple sequential steps including Pd-mediated reductions, thereby significantly improving productivity
Solution Approach 2:
The patent replaces complex chemical reduction steps with a single enzymatic amination reaction. The transaminase catalyst provides stereoselective formation of the lactam stereoisomer directly, eliminating the need for multiple chemical steps and improving overall synthesis efficiency while maintaining stereoisomer specificity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The engineered transaminases demonstrate improved activity and stereoselectivity, enabling efficient conversion of substrate compounds to lactams with high diastereomeric ratios, facilitating the production of specific stereoisomers in high yield.
Implementation Method 1
engineered transaminases capable of converting substrate compound 2 to the product compound 1
Implementation Method 2
biocatalytic amination of dicarbonyl substrate compounds, which can then be converted to heterocycles containing a ring nitrogen atom
Data Source
AI summary
The present disclosure relates to transaminase polypeptides capable of aminating a dicarbonyl substrate, and polynucleotides, vectors, host cells, and methods of making and using the transaminase polypeptides.